JP2004502668A5 - - Google Patents

Download PDF

Info

Publication number
JP2004502668A5
JP2004502668A5 JP2002507768A JP2002507768A JP2004502668A5 JP 2004502668 A5 JP2004502668 A5 JP 2004502668A5 JP 2002507768 A JP2002507768 A JP 2002507768A JP 2002507768 A JP2002507768 A JP 2002507768A JP 2004502668 A5 JP2004502668 A5 JP 2004502668A5
Authority
JP
Japan
Prior art keywords
diethylamino
methoxy
propyl
isobutyrylamino
benzamide according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002507768A
Other languages
English (en)
Japanese (ja)
Other versions
JP4864273B2 (ja
JP2004502668A (ja
Filing date
Publication date
Priority claimed from SE0002531A external-priority patent/SE0002531D0/xx
Application filed filed Critical
Publication of JP2004502668A publication Critical patent/JP2004502668A/ja
Publication of JP2004502668A5 publication Critical patent/JP2004502668A5/ja
Application granted granted Critical
Publication of JP4864273B2 publication Critical patent/JP4864273B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002507768A 2000-07-05 2001-07-03 免疫強化並びに癌、感染および躁鬱病の治療のための置換ベンズアミド Expired - Fee Related JP4864273B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0002531A SE0002531D0 (sv) 2000-07-05 2000-07-05 Immune Enhancement
SE0002531-2 2000-07-05
PCT/SE2001/001526 WO2002002511A1 (en) 2000-07-05 2001-07-03 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness

Publications (3)

Publication Number Publication Date
JP2004502668A JP2004502668A (ja) 2004-01-29
JP2004502668A5 true JP2004502668A5 (enExample) 2005-05-19
JP4864273B2 JP4864273B2 (ja) 2012-02-01

Family

ID=20280373

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002507768A Expired - Fee Related JP4864273B2 (ja) 2000-07-05 2001-07-03 免疫強化並びに癌、感染および躁鬱病の治療のための置換ベンズアミド

Country Status (10)

Country Link
EP (1) EP1299350B1 (enExample)
JP (1) JP4864273B2 (enExample)
AT (1) ATE277890T1 (enExample)
AU (1) AU2001280338A1 (enExample)
CA (1) CA2414146C (enExample)
DE (1) DE60106036T2 (enExample)
ES (1) ES2230350T3 (enExample)
PT (1) PT1299350E (enExample)
SE (1) SE0002531D0 (enExample)
WO (1) WO2002002511A1 (enExample)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE620543A (enExample) *
FR1525M (fr) * 1961-07-25 1962-11-16 Ile De France Médicaments antiémétiques nouveaux.
ES404497A1 (es) * 1972-06-20 1975-06-01 Miquel S A Lab Procedimiento para la obtencion de derivados de benzoileti-lendiaminas sustituidas.
EP0117462A3 (en) * 1983-02-28 1986-08-20 American Cyanamid Company N-(2-4-(1h-imidazol-1-yl)alkyl)arylamides
US4568685A (en) * 1984-02-29 1986-02-04 American Cyanamid Company N-[(1H-1,2,4-Triazol-1-yl)alkyl]-arylamides
US4820715A (en) * 1984-06-28 1989-04-11 Bristol-Myers Company Anti-emetic quinuclidinyl benzamides
CA2074061A1 (en) * 1991-08-26 1993-02-27 Ivo Monkovic Benzamide multidrug resistance reversing agents
JPH10504324A (ja) * 1995-06-07 1998-04-28 デイド、ケミストリー、システムズ、インコーポレイテッド 薬物の免疫原その他の接合体の製造
US6100299A (en) * 1996-03-08 2000-08-08 Oxigene, Inc. N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use
JP3933244B2 (ja) * 1997-04-04 2007-06-20 株式会社資生堂 アルキレンジアミン誘導体及び抗潰瘍剤、抗菌剤
JPH1180107A (ja) * 1997-09-01 1999-03-26 Japan Tobacco Inc 骨形成促進剤及びアミド化合物
JP2001151742A (ja) * 1999-11-26 2001-06-05 Mitsui Chemicals Inc アニリド誘導体及びそれを含有する抗不整脈剤

Similar Documents

Publication Publication Date Title
JP2004517472A5 (enExample)
JP2003509401A5 (enExample)
JP2003520232A5 (enExample)
JP2003517006A5 (enExample)
JP2007516781A5 (enExample)
JP2002532222A5 (enExample)
EE05245B1 (et) N-(1-hdroksmetl-2,3-dihdrokspropl)-1,4,7-triskarboksmetl-1,4,7,10-tetraasatsklododekaani liitiumikompleksid, nende valmistamine ja kasutamine
JPH11310545A5 (enExample)
JP2004502668A5 (enExample)
JP2000169695A5 (enExample)
JP2002114686A5 (enExample)
JP2003516751A5 (enExample)
JP2002255868A5 (enExample)
JP2002523361A5 (enExample)
RU2002111465A (ru) Смесь изомеров 2-моноэтаноламино-5(6)-нитро-1-(тиетанил-3)бензимидазола
JP2005247777A5 (enExample)
JP2001023686A5 (enExample)
JP2003209083A5 (enExample)
JP2004022216A5 (enExample)
RU99116483A (ru) Вещество, обладающее психостимулирующим и антиастеническим действием
JP2003209070A5 (enExample)
RU2002120775A (ru) Глазная пленка
JP2003321417A5 (enExample)
JPS63872U (enExample)
RU2002131009A (ru) Калиевая соль 2-[5(6)-нитро-1-(тиетанил-3)-бензимидазолил-2-тио]уксусной кислоты, проявляющая кардиотоническую активность